📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vertex Pharmaceuticals

1.1 - Company Overview

Vertex Pharmaceuticals Logo

Vertex Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of small molecule drugs for serious diseases, including cystic fibrosis medicines, and research and development of therapies for sickle cell disease, type 1 diabetes, APOL1-mediated kidney disease, pain management, and beta thalassemia.

Products and services

  • Cystic Fibrosis Medicines: Engineers small-molecule medicines for cystic fibrosis, a genetic disease affecting lungs and digestive system, advancing discovery and development of therapies for patients
  • Type 1 Diabetes Research: Investigates cellular-level treatments for type 1 diabetes, aiming to develop innovative therapies by studying disease processes at the cellular level
  • Sickle Cell Disease Research: Architects research-stage treatments for sickle cell disease, focusing on understanding patient experiences and advancing potential therapies through ongoing research and development

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vertex Pharmaceuticals

Instil Bio Logo

Instil Bio

HQ: United States Website
  • Description: Provider of cell therapy solutions focused on tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers, advancing proprietary manufacturing expertise, technology, and data into clinical trials. Programs include a planned registrational study and a first-in-human next-generation engineered TIL, plus FRα CoStAR, a clinical-stage candidate for non-small cell lung cancer (NSCLC).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Instil Bio company profile →
Stada Logo

Stada

HQ: Germany Website
  • Description: Provider of pharmaceuticals and non-prescription consumer health products, operating on three pillars: OTC consumer healthcare, generics, and specialty pharmaceuticals. Sells products in over 120 countries, including acetaminophen, lactulose, Grippostad-C, Vitaprost, Cardiomagnyl, Xefocam Rapid, Aqualor, Edarbi, and Levomekol.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stada company profile →
LEAF Pharmaceuticals Logo

LEAF Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology and healthcare products, including investigational anticancer drugs targeting solid tumors (LEAF-1401, LEAF-1701) with preclinical results showing reduced metastatic tumor burden in lung cancer models, superior performance in colorectal models, and minimal myelosuppression and gastrointestinal toxicity, plus LEAF-1404, a complex generic anticancer medicine manufactured under global cGMP.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LEAF Pharmaceuticals company profile →
Valera Pharmaceuticals Logo

Valera Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical services concentrating on development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Valera Pharmaceuticals company profile →
VivaBioCell Logo

VivaBioCell

HQ: Italy Website
  • Description: Provider of innovative products leveraging proprietary cell culture and tissue engineering technologies for early diagnosis of autoimmune diseases (e.g., scleroderma, graft-versus-host disease) and treatment of oro-dental and maxillo-facial defects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VivaBioCell company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vertex Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vertex Pharmaceuticals

2.2 - Growth funds investing in similar companies to Vertex Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vertex Pharmaceuticals

4.2 - Public trading comparable groups for Vertex Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vertex Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vertex Pharmaceuticals

What does Vertex Pharmaceuticals do?

Vertex Pharmaceuticals is a provider of small molecule drugs for serious diseases, including cystic fibrosis medicines, and research and development of therapies for sickle cell disease, type 1 diabetes, APOL1-mediated kidney disease, pain management, and beta thalassemia.

Who are Vertex Pharmaceuticals's competitors?

Vertex Pharmaceuticals's competitors and similar companies include Instil Bio, Stada, LEAF Pharmaceuticals, Valera Pharmaceuticals, and VivaBioCell.

Where is Vertex Pharmaceuticals headquartered?

Vertex Pharmaceuticals is headquartered in United States.

How many employees does Vertex Pharmaceuticals have?

Vertex Pharmaceuticals has 1,000 employees 🔒.

When was Vertex Pharmaceuticals founded?

Vertex Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Vertex Pharmaceuticals in?

Vertex Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vertex Pharmaceuticals

Who are the top strategic acquirers in Vertex Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Vertex Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vertex Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Vertex Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vertex Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Vertex Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Vertex Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vertex Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vertex Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vertex Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vertex Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vertex Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vertex Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Vertex Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vertex Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vertex Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vertex Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vertex Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vertex Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Vertex Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vertex Pharmaceuticals

Launch login modal Launch register modal